nodes	percent_of_prediction	percent_of_DWPC	metapath
Terlipressin—AVPR2—Arf6 trafficking events—EXOC2—skin cancer	0.0457	0.0964	CbGpPWpGaD
Terlipressin—AVPR1B—Peptide GPCRs—MC1R—skin cancer	0.0284	0.0599	CbGpPWpGaD
Terlipressin—Pregnancy—Imiquimod—skin cancer	0.0242	0.046	CcSEcCtD
Terlipressin—AVPR1A—Peptide GPCRs—MC1R—skin cancer	0.0197	0.0415	CbGpPWpGaD
Terlipressin—AVPR2—Peptide GPCRs—MC1R—skin cancer	0.0195	0.0412	CbGpPWpGaD
Terlipressin—Hyponatraemia—Vismodegib—skin cancer	0.019	0.0361	CcSEcCtD
Terlipressin—AVPR1B—Peptide ligand-binding receptors—MC1R—skin cancer	0.0133	0.0282	CbGpPWpGaD
Terlipressin—Skin exfoliation—Imiquimod—skin cancer	0.0131	0.0249	CcSEcCtD
Terlipressin—AVPR2—G alpha (s) signalling events—MC1R—skin cancer	0.0129	0.0273	CbGpPWpGaD
Terlipressin—Atrial fibrillation—Vemurafenib—skin cancer	0.0123	0.0234	CcSEcCtD
Terlipressin—Pulmonary oedema—Imiquimod—skin cancer	0.0122	0.0232	CcSEcCtD
Terlipressin—Malnutrition—Vismodegib—skin cancer	0.0114	0.0216	CcSEcCtD
Terlipressin—Atrial fibrillation—Imiquimod—skin cancer	0.0105	0.02	CcSEcCtD
Terlipressin—AVPR1B—GPCRs, Class A Rhodopsin-like—MC1R—skin cancer	0.0105	0.0221	CbGpPWpGaD
Terlipressin—Cardiac failure—Imiquimod—skin cancer	0.0102	0.0194	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Vismodegib—skin cancer	0.00963	0.0183	CcSEcCtD
Terlipressin—AVPR1B—GPCR ligand binding—PTCH2—skin cancer	0.00943	0.0199	CbGpPWpGaD
Terlipressin—Skin exfoliation—Bleomycin—skin cancer	0.00931	0.0177	CcSEcCtD
Terlipressin—AVPR1A—Peptide ligand-binding receptors—MC1R—skin cancer	0.00925	0.0195	CbGpPWpGaD
Terlipressin—AVPR2—Peptide ligand-binding receptors—MC1R—skin cancer	0.00919	0.0194	CbGpPWpGaD
Terlipressin—Nervous system disorder—Vismodegib—skin cancer	0.00911	0.0173	CcSEcCtD
Terlipressin—Skin disorder—Vismodegib—skin cancer	0.00902	0.0172	CcSEcCtD
Terlipressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—MC1R—skin cancer	0.00895	0.0189	CbGpPWpGaD
Terlipressin—AVPR2—G alpha (s) signalling events—PTGER4—skin cancer	0.0085	0.0179	CbGpPWpGaD
Terlipressin—Respiratory failure—Temozolomide—skin cancer	0.00837	0.0159	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Vismodegib—skin cancer	0.00802	0.0152	CcSEcCtD
Terlipressin—Skin exfoliation—Temozolomide—skin cancer	0.00785	0.0149	CcSEcCtD
Terlipressin—Acute coronary syndrome—Imiquimod—skin cancer	0.00757	0.0144	CcSEcCtD
Terlipressin—Myocardial infarction—Imiquimod—skin cancer	0.00752	0.0143	CcSEcCtD
Terlipressin—Cardiac disorder—Vemurafenib—skin cancer	0.0075	0.0143	CcSEcCtD
Terlipressin—Abdominal pain—Vismodegib—skin cancer	0.00735	0.014	CcSEcCtD
Terlipressin—Angiopathy—Vemurafenib—skin cancer	0.00733	0.0139	CcSEcCtD
Terlipressin—AVPR1A—GPCRs, Class A Rhodopsin-like—MC1R—skin cancer	0.00724	0.0153	CbGpPWpGaD
Terlipressin—AVPR2—GPCRs, Class A Rhodopsin-like—MC1R—skin cancer	0.00719	0.0152	CbGpPWpGaD
Terlipressin—Malnutrition—Vemurafenib—skin cancer	0.00703	0.0134	CcSEcCtD
Terlipressin—AVPR1B—GPCRs, Class A Rhodopsin-like—PTGER4—skin cancer	0.00687	0.0145	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR ligand binding—MC1R—skin cancer	0.00682	0.0144	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR ligand binding—PTCH2—skin cancer	0.00654	0.0138	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—PTCH2—skin cancer	0.00649	0.0137	CbGpPWpGaD
Terlipressin—Hot flush—Temozolomide—skin cancer	0.00638	0.0121	CcSEcCtD
Terlipressin—Diarrhoea—Vismodegib—skin cancer	0.00636	0.0121	CcSEcCtD
Terlipressin—Menopausal symptoms—Temozolomide—skin cancer	0.00633	0.012	CcSEcCtD
Terlipressin—Angiopathy—Imiquimod—skin cancer	0.00625	0.0119	CcSEcCtD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—MC1R—skin cancer	0.00621	0.0131	CbGpPWpGaD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—MC1R—skin cancer	0.00616	0.013	CbGpPWpGaD
Terlipressin—Malnutrition—Imiquimod—skin cancer	0.006	0.0114	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—skin cancer	0.00595	0.0113	CcSEcCtD
Terlipressin—Vomiting—Vismodegib—skin cancer	0.00591	0.0112	CcSEcCtD
Terlipressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—PTGER4—skin cancer	0.00589	0.0124	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—RHOU—skin cancer	0.00585	0.0124	CbGpPWpGaD
Terlipressin—Cardiac failure—Fluorouracil—skin cancer	0.00564	0.0107	CcSEcCtD
Terlipressin—Nervous system disorder—Vemurafenib—skin cancer	0.00563	0.0107	CcSEcCtD
Terlipressin—Skin disorder—Vemurafenib—skin cancer	0.00558	0.0106	CcSEcCtD
Terlipressin—Respiratory failure—Docetaxel—skin cancer	0.00557	0.0106	CcSEcCtD
Terlipressin—Nausea—Vismodegib—skin cancer	0.00552	0.0105	CcSEcCtD
Terlipressin—Acute coronary syndrome—Bleomycin—skin cancer	0.00538	0.0102	CcSEcCtD
Terlipressin—Myocardial infarction—Bleomycin—skin cancer	0.00535	0.0102	CcSEcCtD
Terlipressin—Skin exfoliation—Docetaxel—skin cancer	0.00522	0.00992	CcSEcCtD
Terlipressin—Hypertension—Imiquimod—skin cancer	0.00518	0.00984	CcSEcCtD
Terlipressin—Chest pain—Imiquimod—skin cancer	0.00511	0.0097	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.00507	0.00964	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Vemurafenib—skin cancer	0.00496	0.00942	CcSEcCtD
Terlipressin—Pulmonary oedema—Docetaxel—skin cancer	0.00487	0.00925	CcSEcCtD
Terlipressin—AVPR1B—GPCR ligand binding—SHH—skin cancer	0.00486	0.0103	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—PTCH2—skin cancer	0.00484	0.0102	CbGpPWpGaD
Terlipressin—Nervous system disorder—Imiquimod—skin cancer	0.0048	0.00912	CcSEcCtD
Terlipressin—Tachycardia—Imiquimod—skin cancer	0.00478	0.00908	CcSEcCtD
Terlipressin—AVPR1A—GPCRs, Class A Rhodopsin-like—PTGER4—skin cancer	0.00476	0.0101	CbGpPWpGaD
Terlipressin—Skin disorder—Imiquimod—skin cancer	0.00476	0.00904	CcSEcCtD
Terlipressin—AVPR2—GPCRs, Class A Rhodopsin-like—PTGER4—skin cancer	0.00473	0.00998	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR ligand binding—MC1R—skin cancer	0.00473	0.00997	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—MC1R—skin cancer	0.00469	0.0099	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR ligand binding—PTCH1—skin cancer	0.00461	0.00972	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR ligand binding—SMO—skin cancer	0.00461	0.00972	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR ligand binding—PTGER4—skin cancer	0.00448	0.00946	CbGpPWpGaD
Terlipressin—AVPR2—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.00448	0.00945	CbGpPWpGaD
Terlipressin—Dyspnoea—Imiquimod—skin cancer	0.00436	0.00829	CcSEcCtD
Terlipressin—Hot flush—Docetaxel—skin cancer	0.00424	0.00806	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Imiquimod—skin cancer	0.00423	0.00803	CcSEcCtD
Terlipressin—Menopausal symptoms—Docetaxel—skin cancer	0.00421	0.00799	CcSEcCtD
Terlipressin—Atrial fibrillation—Docetaxel—skin cancer	0.00419	0.00796	CcSEcCtD
Terlipressin—Acute coronary syndrome—Fluorouracil—skin cancer	0.00418	0.00794	CcSEcCtD
Terlipressin—Myocardial infarction—Fluorouracil—skin cancer	0.00415	0.00789	CcSEcCtD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—PTGER4—skin cancer	0.00408	0.00861	CbGpPWpGaD
Terlipressin—Cardiac failure—Docetaxel—skin cancer	0.00407	0.00773	CcSEcCtD
Terlipressin—AVPR1A—Signaling Pathways—RHOU—skin cancer	0.00406	0.00856	CbGpPWpGaD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—PTGER4—skin cancer	0.00405	0.00855	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—RHOU—skin cancer	0.00403	0.0085	CbGpPWpGaD
Terlipressin—Hyponatraemia—Docetaxel—skin cancer	0.00399	0.00757	CcSEcCtD
Terlipressin—Diarrhoea—Vemurafenib—skin cancer	0.00393	0.00746	CcSEcCtD
Terlipressin—Abdominal pain—Imiquimod—skin cancer	0.00387	0.00735	CcSEcCtD
Terlipressin—AVPR1B—GPCR downstream signaling—MC1R—skin cancer	0.00385	0.00813	CbGpPWpGaD
Terlipressin—Cardiac disorder—Temozolomide—skin cancer	0.00383	0.00728	CcSEcCtD
Terlipressin—Angiopathy—Temozolomide—skin cancer	0.00375	0.00712	CcSEcCtD
Terlipressin—Vomiting—Vemurafenib—skin cancer	0.00365	0.00694	CcSEcCtD
Terlipressin—Chest pain—Bleomycin—skin cancer	0.00363	0.00689	CcSEcCtD
Terlipressin—Headache—Vemurafenib—skin cancer	0.0036	0.00683	CcSEcCtD
Terlipressin—Malnutrition—Temozolomide—skin cancer	0.00359	0.00683	CcSEcCtD
Terlipressin—AVPR1B—Signaling by GPCR—MC1R—skin cancer	0.0035	0.00739	CbGpPWpGaD
Terlipressin—Nausea—Vemurafenib—skin cancer	0.00341	0.00648	CcSEcCtD
Terlipressin—AVPR1A—GPCR ligand binding—SHH—skin cancer	0.00337	0.00711	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PTCH2—skin cancer	0.00335	0.00708	CbGpPWpGaD
Terlipressin—Diarrhoea—Imiquimod—skin cancer	0.00335	0.00637	CcSEcCtD
Terlipressin—AVPR2—GPCR ligand binding—SHH—skin cancer	0.00334	0.00706	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PTCH2—skin cancer	0.00333	0.00703	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR ligand binding—PTCH1—skin cancer	0.00319	0.00674	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR ligand binding—SMO—skin cancer	0.00319	0.00674	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—PTCH1—skin cancer	0.00317	0.00669	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—SMO—skin cancer	0.00317	0.00669	CbGpPWpGaD
Terlipressin—Vomiting—Imiquimod—skin cancer	0.00311	0.00592	CcSEcCtD
Terlipressin—AVPR1A—GPCR ligand binding—PTGER4—skin cancer	0.00311	0.00656	CbGpPWpGaD
Terlipressin—Hypertension—Temozolomide—skin cancer	0.0031	0.0059	CcSEcCtD
Terlipressin—Dyspnoea—Bleomycin—skin cancer	0.0031	0.00589	CcSEcCtD
Terlipressin—AVPR2—GPCR ligand binding—PTGER4—skin cancer	0.00309	0.00651	CbGpPWpGaD
Terlipressin—Headache—Imiquimod—skin cancer	0.00307	0.00583	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.00304	0.00578	CcSEcCtD
Terlipressin—Acute coronary syndrome—Docetaxel—skin cancer	0.00302	0.00573	CcSEcCtD
Terlipressin—Myocardial infarction—Docetaxel—skin cancer	0.003	0.0057	CcSEcCtD
Terlipressin—Nausea—Imiquimod—skin cancer	0.00291	0.00553	CcSEcCtD
Terlipressin—Nervous system disorder—Temozolomide—skin cancer	0.00288	0.00547	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—PTCH2—skin cancer	0.00286	0.00603	CbGpPWpGaD
Terlipressin—Skin disorder—Temozolomide—skin cancer	0.00285	0.00542	CcSEcCtD
Terlipressin—Chest pain—Fluorouracil—skin cancer	0.00282	0.00536	CcSEcCtD
Terlipressin—AVPR1A—GPCR downstream signaling—MC1R—skin cancer	0.00267	0.00564	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—MC1R—skin cancer	0.00265	0.0056	CbGpPWpGaD
Terlipressin—Nervous system disorder—Fluorouracil—skin cancer	0.00265	0.00504	CcSEcCtD
Terlipressin—Tachycardia—Fluorouracil—skin cancer	0.00264	0.00501	CcSEcCtD
Terlipressin—Dyspnoea—Temozolomide—skin cancer	0.00262	0.00497	CcSEcCtD
Terlipressin—Abdominal pain—Dactinomycin—skin cancer	0.00256	0.00487	CcSEcCtD
Terlipressin—Cardiac disorder—Docetaxel—skin cancer	0.00255	0.00484	CcSEcCtD
Terlipressin—AVPR1B—GPCR downstream signaling—PTGER4—skin cancer	0.00253	0.00535	CbGpPWpGaD
Terlipressin—Gastrointestinal disorder—Temozolomide—skin cancer	0.00253	0.00481	CcSEcCtD
Terlipressin—AVPR1B—Signaling by GPCR—SHH—skin cancer	0.00249	0.00526	CbGpPWpGaD
Terlipressin—Angiopathy—Docetaxel—skin cancer	0.00249	0.00473	CcSEcCtD
Terlipressin—AVPR1A—Signaling by GPCR—MC1R—skin cancer	0.00243	0.00512	CbGpPWpGaD
Terlipressin—Dyspnoea—Fluorouracil—skin cancer	0.00241	0.00458	CcSEcCtD
Terlipressin—AVPR2—Signaling by GPCR—MC1R—skin cancer	0.00241	0.00508	CbGpPWpGaD
Terlipressin—Malnutrition—Docetaxel—skin cancer	0.00239	0.00454	CcSEcCtD
Terlipressin—AVPR1B—Signaling by GPCR—SMO—skin cancer	0.00236	0.00499	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—PTCH1—skin cancer	0.00236	0.00499	CbGpPWpGaD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—skin cancer	0.00233	0.00493	CbGpPWpGaD
Terlipressin—Gastrointestinal disorder—Fluorouracil—skin cancer	0.00233	0.00443	CcSEcCtD
Terlipressin—Abdominal pain—Temozolomide—skin cancer	0.00232	0.00441	CcSEcCtD
Terlipressin—AVPR1B—Signaling by GPCR—PTGER4—skin cancer	0.0023	0.00486	CbGpPWpGaD
Terlipressin—Diarrhoea—Dactinomycin—skin cancer	0.00222	0.00422	CcSEcCtD
Terlipressin—Vomiting—Bleomycin—skin cancer	0.00221	0.0042	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—GLI2—skin cancer	0.00217	0.00457	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MC1R—skin cancer	0.00207	0.00436	CbGpPWpGaD
Terlipressin—Nausea—Bleomycin—skin cancer	0.00207	0.00393	CcSEcCtD
Terlipressin—Hypertension—Docetaxel—skin cancer	0.00206	0.00392	CcSEcCtD
Terlipressin—Vomiting—Dactinomycin—skin cancer	0.00206	0.00392	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—GLI1—skin cancer	0.00204	0.0043	CbGpPWpGaD
Terlipressin—Chest pain—Docetaxel—skin cancer	0.00204	0.00387	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.00202	0.00384	CcSEcCtD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—skin cancer	0.00201	0.00424	CbGpPWpGaD
Terlipressin—Diarrhoea—Temozolomide—skin cancer	0.00201	0.00381	CcSEcCtD
Terlipressin—AVPR1A—Signaling Pathways—PTCH2—skin cancer	0.00198	0.00418	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PTCH2—skin cancer	0.00197	0.00415	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—SUFU—skin cancer	0.00193	0.00408	CbGpPWpGaD
Terlipressin—Nausea—Dactinomycin—skin cancer	0.00193	0.00366	CcSEcCtD
Terlipressin—Nervous system disorder—Docetaxel—skin cancer	0.00191	0.00364	CcSEcCtD
Terlipressin—Tachycardia—Docetaxel—skin cancer	0.0019	0.00362	CcSEcCtD
Terlipressin—Skin disorder—Docetaxel—skin cancer	0.00189	0.0036	CcSEcCtD
Terlipressin—Vomiting—Temozolomide—skin cancer	0.00187	0.00354	CcSEcCtD
Terlipressin—Diarrhoea—Fluorouracil—skin cancer	0.00185	0.00351	CcSEcCtD
Terlipressin—Headache—Temozolomide—skin cancer	0.00184	0.00349	CcSEcCtD
Terlipressin—AVPR1A—GPCR downstream signaling—PTGER4—skin cancer	0.00176	0.00371	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—PTGER4—skin cancer	0.00174	0.00368	CbGpPWpGaD
Terlipressin—Nausea—Temozolomide—skin cancer	0.00174	0.00331	CcSEcCtD
Terlipressin—Dyspnoea—Docetaxel—skin cancer	0.00174	0.00331	CcSEcCtD
Terlipressin—AVPR1A—Signaling by GPCR—SHH—skin cancer	0.00173	0.00365	CbGpPWpGaD
Terlipressin—Vomiting—Fluorouracil—skin cancer	0.00172	0.00327	CcSEcCtD
Terlipressin—AVPR2—Signaling by GPCR—SHH—skin cancer	0.00172	0.00362	CbGpPWpGaD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	0.00171	0.00361	CbGpPWpGaD
Terlipressin—Headache—Fluorouracil—skin cancer	0.00169	0.00322	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Docetaxel—skin cancer	0.00168	0.0032	CcSEcCtD
Terlipressin—AVPR1A—Signaling by GPCR—PTCH1—skin cancer	0.00164	0.00346	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—SMO—skin cancer	0.00164	0.00346	CbGpPWpGaD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	0.00163	0.00345	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PTCH1—skin cancer	0.00163	0.00343	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—SMO—skin cancer	0.00163	0.00343	CbGpPWpGaD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—skin cancer	0.00162	0.00342	CbGpPWpGaD
Terlipressin—Nausea—Fluorouracil—skin cancer	0.00161	0.00305	CcSEcCtD
Terlipressin—AVPR1A—Signaling by GPCR—PTGER4—skin cancer	0.00159	0.00337	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PTGER4—skin cancer	0.00158	0.00334	CbGpPWpGaD
Terlipressin—Abdominal pain—Docetaxel—skin cancer	0.00154	0.00293	CcSEcCtD
Terlipressin—AVPR1A—Signaling Pathways—GLI2—skin cancer	0.0015	0.00317	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—GLI2—skin cancer	0.00149	0.00315	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—SHH—skin cancer	0.00147	0.00311	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—RASA1—skin cancer	0.00146	0.00309	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MC1R—skin cancer	0.00143	0.00302	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MC1R—skin cancer	0.00142	0.003	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—GLI1—skin cancer	0.00141	0.00298	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—GLI1—skin cancer	0.0014	0.00296	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—SMO—skin cancer	0.0014	0.00295	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PTCH1—skin cancer	0.0014	0.00295	CbGpPWpGaD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—skin cancer	0.00139	0.00294	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PTGER4—skin cancer	0.00136	0.00287	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—SUFU—skin cancer	0.00134	0.00283	CbGpPWpGaD
Terlipressin—Diarrhoea—Docetaxel—skin cancer	0.00133	0.00254	CcSEcCtD
Terlipressin—AVPR2—Signaling Pathways—SUFU—skin cancer	0.00133	0.0028	CbGpPWpGaD
Terlipressin—Vomiting—Docetaxel—skin cancer	0.00124	0.00236	CcSEcCtD
Terlipressin—Headache—Docetaxel—skin cancer	0.00122	0.00232	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—FOXO4—skin cancer	0.0012	0.00253	CbGpPWpGaD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	0.00118	0.0025	CbGpPWpGaD
Terlipressin—Nausea—Docetaxel—skin cancer	0.00116	0.0022	CcSEcCtD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	0.00113	0.00239	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—SHH—skin cancer	0.00102	0.00215	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—RASA1—skin cancer	0.00101	0.00214	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—SHH—skin cancer	0.00101	0.00214	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—RASA1—skin cancer	0.00101	0.00213	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PTCH1—skin cancer	0.000968	0.00204	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—SMO—skin cancer	0.000968	0.00204	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PTCH1—skin cancer	0.000961	0.00203	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—SMO—skin cancer	0.000961	0.00203	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PTGER4—skin cancer	0.000942	0.00199	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PTGER4—skin cancer	0.000935	0.00197	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—FOXO4—skin cancer	0.000832	0.00176	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—FOXO4—skin cancer	0.000826	0.00174	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—TERT—skin cancer	0.000802	0.00169	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—NRAS—skin cancer	0.000676	0.00143	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—BRAF—skin cancer	0.000635	0.00134	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—KRAS—skin cancer	0.000582	0.00123	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TERT—skin cancer	0.000556	0.00117	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TERT—skin cancer	0.000552	0.00116	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—HRAS—skin cancer	0.000494	0.00104	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—IL6—skin cancer	0.000473	0.000998	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—NRAS—skin cancer	0.000468	0.000988	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—NRAS—skin cancer	0.000465	0.000981	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—BRAF—skin cancer	0.00044	0.000929	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—BRAF—skin cancer	0.000437	0.000922	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—KRAS—skin cancer	0.000403	0.000851	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—KRAS—skin cancer	0.0004	0.000845	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—NRAS—skin cancer	0.000399	0.000842	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—KRAS—skin cancer	0.000344	0.000725	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—HRAS—skin cancer	0.000343	0.000723	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—HRAS—skin cancer	0.00034	0.000718	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—IL6—skin cancer	0.000328	0.000692	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—IL6—skin cancer	0.000326	0.000687	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—TP53—skin cancer	0.000305	0.000644	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—HRAS—skin cancer	0.000292	0.000616	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IL6—skin cancer	0.000279	0.00059	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—NRAS—skin cancer	0.000277	0.000584	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—NRAS—skin cancer	0.000275	0.00058	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—KRAS—skin cancer	0.000238	0.000503	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—KRAS—skin cancer	0.000236	0.000499	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TP53—skin cancer	0.000212	0.000447	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TP53—skin cancer	0.00021	0.000443	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—HRAS—skin cancer	0.000202	0.000427	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—HRAS—skin cancer	0.000201	0.000424	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IL6—skin cancer	0.000194	0.000409	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IL6—skin cancer	0.000192	0.000406	CbGpPWpGaD
